
Loading, please wait...

Loading, please wait...

The All India Institute of Medical Sciences Jammu has entered a transformative administrative phase. Recently, eminent physician and academic leader Prof. (Dr.) Sanjeev Sinha officially assumed charge as the new AIIMS Jammu Executive Director and Chief Executive Officer. Consequently, this high-profile appointment marks an essential milestone in the expansion of northern India's premier healthcare infrastructure. Prof. Sinha transitions to this pivotal post on deputation from the prestigious AIIMS New Delhi. Furthermore, his arrival brings decades of advanced clinical practice, academic mentorship, and translational biomedical research to the region. Healthcare leaders across the country anticipate substantial progress in clinical services and medical training under his direct guidance.
The Appointments Committee of the Cabinet, chaired by the Prime Minister, formally approved the deputation of Dr. Sanjeev Sinha. According to the official notification issued by the Department of Personnel and Training, the tenure spans three years from the date of assumption of charge. Alternatively, the tenure remains valid until he attains the age of seventy years or until further governmental orders. This appointment follows the conclusion of the leadership tenure of Prof. (Dr.) D. N. Sharma. Prof. Sharma served the apex institution with distinction as Executive Director and CEO since January 2026. During his tenure, Dr. Sharma guided the foundational phases of clinical expansion and campus infrastructure development.
Moreover, the administrative handover at AIIMS Vijaypur in Samba district took place seamlessly. Faculty members, resident physicians, and administrative staff warmly received the new leadership. In addition, the central administration underscored the importance of continuity during this rapid development phase. The Union Ministry of Health and Family Welfare recommended this transition to maintain institutional excellence. As a result, the institution is now well positioned to accelerate its operational milestones. Stakeholders throughout Jammu and Kashmir look forward to comprehensive health system upgrades.
Before assuming his executive position in Jammu, Prof. Sanjeev Sinha built a celebrated career at AIIMS New Delhi. Serving as a senior professor in the Department of Medicine, he managed complex clinical cases across several decades. Furthermore, Dr. Sinha actively mentored generations of undergraduate medical students, postgraduate residents, and doctoral scholars. His clinical acumen spans internal medicine, infectious diseases, and respiratory illnesses. Consequently, he has earned widespread national and international recognition for his contributions to medical science.
In addition to his bedside teaching, Dr. Sinha has spearheaded numerous pioneering research initiatives. He has authored dozens of peer-reviewed scientific papers in prestigious medical journals. His investigative work covers diagnostic bronchoscopy yields, pulmonary infections, metabolic complications, and chronic infectious diseases. Therefore, his rich investigative portfolio reinforces the vital link between laboratory discovery and patient outcomes. Additionally, his clinical trial leadership has helped shape several national disease management guidelines. By bringing this deep academic perspective to Jammu, Dr. Sinha will cultivate an environment of scientific inquiry and clinical excellence among young medical professionals.
As the new AIIMS Jammu Executive Director, Prof. Sinha outlines an ambitious roadmap for institutional advancement. First and foremost, his primary objective centers on expanding specialized clinical disciplines to serve underserved regional populations. Moreover, his strategic plan emphasizes establishing advanced super-specialty departments, modern critical care units, and robust diagnostic infrastructure. By modernizing these tertiary facilities, the hospital aims to reduce patient transfers to distant metropolitan centres. Therefore, local communities will receive prompt, high-quality medical care close to home.
Simultaneously, Prof. Sinha intends to embed a rigorous culture of evidence-based medicine into daily hospital workflows. Clinical departments will adopt standardized therapeutic protocols aligned with global best practices. Additionally, the administration will prioritize digital health systems, automated laboratory pathways, and paperless electronic medical records. Such innovations streamline patient management and minimize administrative bottlenecks. Furthermore, Dr. Sinha advocates strongly for interdisciplinary collaboration among medical, surgical, and diagnostic faculties. Consequently, integrated tumor boards, antimicrobial stewardship teams, and multispecialty clinical panels will become standard institutional practices.
The establishment of AIIMS Jammu under the Pradhan Mantri Swasthya Suraksha Yojana represents a historic health initiative. Historically, patients in the Union Territory often travelled extensive distances for advanced interventions. Now, AIIMS Vijaypur offers high-level tertiary healthcare within the region. Prof. Sinha's leadership will accelerate the commissioning of specialized operating theatres, advanced cardiac catheterization laboratories, and state-of-the-art radiation oncology suites. As a result, patients facing complex oncology, cardiology, or neurological disorders will receive timely, comprehensive therapy.
Furthermore, the institute plans to expand round-the-clock emergency medicine and trauma services. Because Jammu connects strategic national highways, rapid trauma care remains an urgent public health requirement. Therefore, the hospital will upgrade its triage systems, intensive care beds, and emergency surgical suites. In addition, Prof. Sinha emphasizes compassionate, patient-centered care alongside technological modernization. Hospital administration will streamline outpatient department workflows, reduce waiting times, and enhance patient counseling services. Through these collective measures, AIIMS Jammu will establish itself as a trusted regional healthcare beacon.
Medical education stands as another core pillar of Prof. Sinha's institutional vision. AIIMS Jammu continues to train undergraduate MBBS students, nursing candidates, and allied health professionals. Under the new leadership, the institute will expand postgraduate residency programs and super-specialty fellowships. Furthermore, the academic curriculum will integrate hands-on simulation training, clinical case conferences, and early research exposure. Thus, medical trainees will develop exceptional clinical competencies alongside ethical communication skills.
Moreover, the institution will foster vibrant international and national academic partnerships. Dr. Sinha aims to create dedicated intramural research grants, modern biomedical laboratories, and structured mentorship programs. Faculty members will receive active institutional support to secure national competitive research funding. Consequently, students and junior researchers can participate in impactful epidemiological studies and translational clinical trials. In addition, regular continuing medical education workshops and national conferences will keep regional physicians abreast of emerging therapeutic advances. Ultimately, these educational initiatives ensure the development of skilled clinicians who can address India's evolving healthcare challenges.
Q1: Who has been appointed as the new Executive Director and CEO of AIIMS Jammu?
Prof. (Dr.) Sanjeev Sinha has assumed charge as the new Executive Director and CEO of AIIMS Jammu. He joins the apex institute on deputation from AIIMS New Delhi, where he served as a renowned professor in the Department of Medicine. Prof. Sinha brings extensive clinical expertise, academic mentorship, and translational research leadership to guide the ongoing development of AIIMS Jammu.
Q2: What is the tenure and authority behind Dr. Sanjeev Sinha's appointment at AIIMS Jammu?
The Appointments Committee of the Cabinet approved Dr. Sinha's deputation based on recommendations from the Union Ministry of Health and Family Welfare. The official appointment spans a tenure of three years from assuming charge, or until attaining the age of seventy years, or until further orders. He succeeds Prof. (Dr.) D. N. Sharma, whose executive tenure concluded in August 2026.
Q3: What are the primary institutional priorities under Dr. Sanjeev Sinha's leadership?
Dr. Sinha's strategic vision focuses on expanding super-specialty clinical services, strengthening emergency and critical trauma care, and elevating undergraduate and postgraduate medical education. Furthermore, his leadership emphasizes evidence-based clinical protocols, modern digital hospital infrastructure, and interdisciplinary scientific collaboration. Additionally, the institute will expand cutting-edge biomedical research opportunities, faculty development initiatives, and specialized training programs for healthcare professionals across the region.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Prof. (Dr.) Sanjeev Sinha from AIIMS New Delhi has assumed charge as Executive Director and CEO of AIIMS Jammu following ACC approval. This leadership transition aims to accelerate tertiary healthcare delivery, foster collaborative clinical research, and elevate undergraduate and postgraduate medical education.
Today

The NICE framework introduces a two-step non-invasive approach combining DECENT-plus computational purification and machine learning to analyze embryo cfDNA from spent culture medium, overcoming maternal contamination and enabling accurate embryo prioritization in assisted reproductive technology.
Today

As ultra-processed food consumption surges, India's food regulator faces intense judicial scrutiny from the Supreme Court over delayed front-of-pack warning labels. Discover how industry resistance, dual product formulation standards, and public health demands shape this critical cardiometabolic debate.
Today

A recent study highlights that regional trauma transfer networks successfully deliver timely surgical stabilization of rib fractures for rural patients, matching urban operative timelines despite higher initial injury severity.
Today

A breakthrough multimodal AI framework combines retinal vascular geometric parameters and clinical data to achieve high diagnostic and prognostic accuracy in diabetic nephropathy, offering a powerful non-invasive alternative to traditional renal biopsy.
Today